natgillin/translations-raw huggingface dataset:
Since it is less well absorbed from an empty stomach, Pravafenix should always be taken with food (see sections 4.5. and 5.2).
Ker se zdravilo Pravafenix na prazen želodec slabše absorbira, ga je treba vedno vzeti skupaj s hrano (glejte poglavji 4.5 in 5.2).
Since it may induce dizziness, somnolence or fatigue, patients should be cautioned not to drive or use machines if such symptoms occur.
Ker lahko povzroči omotičnost, somnolenco ali utrujenost, je treba bolnike opozoriti, naj ne vozijo in naj ne upravljajo strojev, če se pojavijo tovrstni simptomi.
Since it takes approximately two months to eliminate fingolimod from the body on stopping treatment (see section 4.4), the potential risk to the foetus may persist and contraception should be continued during that period.
Po prekinitvi jemanja traja približno dva meseca, da se fingolimod izloči iz telesa (glejte poglavje 4.4), zato lahko v tem obdobju ostaja tveganje za plod povečano in je treba s kontracepcijo nadaljevati.
Since ketoconazole is excreted in the milk, mothers who are under treatment must not breast-feed whilst being treated with Ketoconazole HRA (see section 4.3).
Ker se ketokonazol izloča v mleko, matere med zdravljenjem z zdravilom Ketokonazol HRA ne smejo dojiti (glejte poglavje 4.3).
Since lamivudine is dialysable, continuous haemodialysis could be used in the treatment of overdose, although this has not been studied.
Ker se lamivudin izloča z dializo, se za zdravljenje prevelikega odmerjanja lahko uporabi neprekinjena hemodializa, vendar tega še niso preučili.
Since LeukoScan cross-reacts with CEA, it should be borne in mind that it may interact with CEA producing tumours.
Ker zdravilo LeukoScan navzkrižno reagira s CEA (karcinoembrionski antigen), je potrebno upoštevati, da lahko reagira s tumorji, ki proizvajajo CEA.
Since limited data are available across all hepatic impairment groups and across all renal impairment groups, caution is advised in the use of TRISENOX in patients with hepatic and/or renal impairment.
Ker o uporabi zdravila TRISENOX ni zadostnih podatkov za nobeno skupino bolnikov z jetrno ali ledvično okvaro, je potrebna previdnost pri uporabi tega zdravila pri bolnikih z jetrno in/ali ledvično okvaro.
Since limited data are available across all hepatic impairment groups, caution is advised in the use of TRISENOX in patients with hepatic impairment.
Ker so na voljo omejeni podatki za vse skupine bolnikov z jetrno okvaro, se pri uporabi zdravila TRISENOX priporoča previdnost pri bolnikih z jetrno okvaro.
Since limited data are available across all renal impairment groups, caution is advised in the use of TRISENOX in patients with renal impairment.
Ker so na voljo omejeni podatki za vse skupine bolnikov z ledvično okvaro, se pri uporabi zdravila TRISENOX priporoča previdnost pri bolnikih z ledvično okvaro.
Since liver dysfunction (increases in transaminases and bilirubin) may occur (especially after doses of above 1 000 mg/m2 dexrazoxane), it is recommended that routine liver function tests be performed before each administration of dexrazoxane in patients with known liver function disorders.
Ker lahko, zlasti po odmerkih deksrazoksana nad 1.000 mg/m2, pride do disfunkcije jeter (zvišane vrednosti transaminaz in bilirubina), je pri bolnikih z dokazano okvaro jeter priporočljivo opraviti redne preiskave jetrne funkcije pred vsakim odmerkom deksrazoksana.
Since Loxicom is a generic medicine, studies have been conducted to determine that it is bioequivalent to the reference medicine, Metacam.
Ker je zdravilo Loxicom generično zdravilo, so bile študije omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Metacam.
Since metabolism of R-warfarin was not affected, these results indicate that capecitabine down- regulates isozyme 2C9, but has no effect on isozymes 1A2 and 3A4.
Ker na presnovo R-varfarina ni bilo vpliva, ti rezultati nakazujejo, da kapecitabin zavira izoencim 2C9, ne vpliva pa na izoencima 1A2 in 3A4.
Since more than one infusion-related reaction may have occurred during any single infusion, the above numbers are likely to over estimate the true incidence of infusion reactions.
Med enim infundiranjem se lahko pojavi več kot en učinek, povezan z infundiranjem, zato so navedene številke verjetno večje od dejanske incidence učinkov pri infundiranju.
Since most medicinal product-induced photosensitivity reactions are caused by wavelengths within the UV-A range, sunscreen that strongly absorbs UV-A is recommended.
Večino fotosenzibilizacijskih reakcij, povezanih z uporabo zdravil, povzročajo valovne dolžine v ultravijoličnem razponu, zato je priporočljiva uporaba kreme za sončenje, ki močno absorbira žarke UV-A.
Since mTOR is involved in the control of cell division and the growth of blood vessels, Afinitor prevents the division of tumour cells and reduces their blood supply.
Ker mTOR sodeluje pri nadzoru delitve celic in rasti krvnih žil, zdravilo Afinitor preprečuje delitev tumorskih celic ter zmanjšuje njihovo oskrbo s krvjo.
Since mTOR is involved in the control of cell division, Torisel prevents the division of cancer cells, slowing down the growth and spread of the cancer.
Ker je beljakovina mTOR vključena v nadzor nad deljenjem celic, zdravilo Torisel preprečuje deljenje rakavih celic in tako upočasni rast in širjenje raka.
Since neither body weight nor Body Mass Index (BMI) had influence on the clearance of nevirapine, the effect of gender cannot be explained by body size.
Ker na nevirapinov očistek ni vplivala telesna masa niti indeks telesne mase (ITM), vpliva spola ne moremo pojasniti s telesno velikostjo.
Since no data are available on the compatibility of Simulect with other intravenous substances, Simulect should not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker ni podatkov o združljivosti Simulecta z drugimi zdravili za intravensko uporabo, Simulecta ne smemo mešati z drugimi zdravili in ga moramo vedno dajati po ločenem infuzijskem kanalu.
Since no data are available on the compatibility of Simulect with other intravenous substances, Simulect should not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker ni podatkov o združljivosti Simulecta z drugimi zdravili za intravensko uporabo, Simulecta ne smemo mešati z drugimi zdravili/snovmi in ga moramo vedno dajati po ločenem infuzijskem kanalu.
Since no data are available on the compatibility of Simulect with other medicinal products intended for intravenous administration, Simulect should not be mixed with other medicinal products and should always be given through a separate infusion line.
Ker ni na voljo nobenih podatkov o združljivosti Simulecta z drugimi zdravili za intravensko uporabo, se ne sme mešati z drugimi zdravili oziroma snovmi in se mora vselej dati po posebnem infuzijskem sistemu.
Since no data are available on the compatibility of Simulect with other medicinal products intended for intravenous administration, Simulect should not be mixed with other medicinal products and should always be given through a separate infusion line.
Ker ni na voljo nobenih podatkov o združljivosti Simulecta z drugimi zdravili za intravensko uporabo, se Simulecta ne sme mešati z drugimi zdravili in se mora vselej dati po posebnem infuzijskem sistemu.
Since no data are available on the compatibility of Zoledronic Acid Accord with other intravenously administered substances, Zoledronic Acid Accord must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker o združljivosti zdravila Zoledronska kislina Accord z drugimi intravensko dajanimi snovmi ni na voljo nikakršnih podatkov, zdravila Zoledronska kislina Accord ne smete mešati z drugimi zdravili ali snovmi in jo morate vedno dajati po ločenem infuzijskem sistemu.
Since no data are available on the compatibility of Zoledronic acid Actavis with other intravenously administered substances, Zoledronic acid Actavis must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker podatkov o kompatibilnosti zdravila Zoledronska kislina Actavis z drugimi intravensko uporabljanimi snovmi ni, se zdravila Zoledronska kislina Actavis ne sme mešati z drugimi zdravili/snovmi in ga je vedno treba dati z ločenim infuzijskim sistemom.
Since no data are available on the compatibility of Zoledronic Acid Hospira with other intravenously administered substances, Zoledronic Acid Hospira must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker o združljivosti zdravila Zoledronska kislina Hospira z drugimi intravensko dajanimi snovmi ni na voljo nikakršnih podatkov, zdravila Zoledronska kislina Hospira ne smete mešati z drugimi zdravili ali snovmi in jo moramo vedno dajati po ločenem infuzijskem sistemu.
Since no data are available on the compatibility of Zoledronic acid medac with other intravenously administered substances, Zoledronic acid medac must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker o združljivosti zdravila Zoledronska kislina medac z drugimi intravensko dajanimi snovmi ni na voljo nikakršnih podatkov, zdravila Zoledronska kislina medac ne smete mešati z drugimi zdravili ali snovmi in jo morate vedno dajati po ločenem infuzijskem sistemu.
Since no data are available on the compatibility of Zoledronic acid Mylan with other intravenously administered substances, Zoledronic acid Mylan must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker o združljivosti zdravila Zoledronska kislina Mylan z drugimi intravensko dajanimi snovmi ni na voljo nikakršnih podatkov, zdravila Zoledronska kislina Mylan ne smete mešati z drugimi zdravili ali snovmi in jo morate vedno dajati po ločenem infuzijskem sistemu.
Since no data are available on the compatibility of Zoledronic acid Teva with other intravenously administered substances, Zoledronic acid Teva must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker o združljivosti zdravila Zoledronska kislina Teva z drugimi intravensko dajanimi snovmi ni na voljo nikakršnih podatkov, zdravila Zoledronska kislina Teva ne smete mešati z drugimi zdravili ali snovmi in jo morate vedno dajati po ločenem infuzijskem sistemu.
Since no data are available on the compatibility of zoledronic acid with other intravenously administered substances, zoledronic acid must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker o združljivosti zdravila Zoledronska kislina Teva z drugimi intravensko dajanimi snovmi ni na voljo nikakršnih podatkov, zdravila Zoledronska kislina Teva ne smete mešati z drugimi zdravili ali snovmi in jo moramo vedno dajati po ločenem infuzijskem sistemu.
Since no data are available on the compatibility of Zometa with other intravenously administered substances, Zometa must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker o združljivosti zdravila Zometa z drugimi intravensko dajanimi snovmi ni na voljo nikakršnih podatkov, zdravila Zometa ne smete mešati z drugimi zdravili ali snovmi in jo moramo vedno dajati po ločenem infuzijskem sistemu.
Since no data are available on the compatibility of Zometa with other intravenously administered substances, Zometa must not be mixed with other medications/substances and should always be given through a separate infusion line.
Ker o združljivosti zdravila Zometa z drugimi intravensko dajanimi snovmi ni na voljo nikakršnih podatkov, zdravila Zometa ne smete mešati z drugimi zdravili ali snovmi in jo morate vedno dajati po ločenem infuzijskem sistemu.
Since no dose recommendation
Ker za itrakonazol ni mogoče dati
Since no dose recommendation can be made for itraconazole when used with Atripla, an alternative antifungal treatment should be considered.
Pri sočasni uporabi z zdravilom Atripla je treba dnevni odmerek rifabutina povečati za 50 %.
Since no natural outbreaks of ND and MD occurred the chickens were challenged (exposed to infection) in the laboratory.
Ker ni bilo nobenega naravnega izbruha bolezni Newcastle in Marekove bolezni, so piščance okužbi izpostavili v laboratoriju.
Since no preservative is present, it is recommended that administration is started as soon as possible after dilution.
Ker raztopina ne vsebuje konzervansov je priporočljivo, da začnete z dajanjem čim prej po redčenju.
Since no preservative is present, it is recommended that the administration of the solution for infusion is to be started as soon as possible and within 3 hours of reconstitution and dilution.
Ker raztopina za infundiranje ne vsebuje konzervansa, priporočamo, da z dajanjem infuzije začnete čim prej in v roku 3 ur po rekonstituciji in redčenju.
Since no preservative is present, it is recommended that the administration of the solution for infusion is to be started as soon as possible and within 3 hours of reconstitution and dilution.
Ker raztopina za infundiranje ne vsebuje konzervansa, priporočamo, da z dajanjem infuzije začnete čimprej in v roku 3 ur po rekonstituciji in redčenju.
Since olanzapine is metabolised by CYP1A2, substances that can specifically induce or inhibit this isoenzyme may affect the pharmacokinetics of olanzapine.
Olanzapin se presnavlja z izoencimom 1A2 citokroma P450 (CYP1A2), zato lahko snovi, ki specifično povečajo ali zavirajo delovanje tega izoencima, vplivajo na farmakokinetiko olanzapina.
Since only limited experience exists in patients with moderate renal impairment (n=35), a lower starting dose of 4 mg is recommended.
Ker so izkušnje pri bolnikih z zmerno okvaro delovanja ledvic le omejene (n=35), je priporočljiv nižji začetni odmerek 4 mg.
Since oral cysteamine doesn’t prevent deposits of cystine crystals in the eye, you should continue taking cysteamine eye drops as prescribed by your doctor.
Ker peroralna uporaba cisteamina ne preprečuje nalaganja cistinskih kristalov v očesu, morate še naprej uporabljati kapljice za oko s cisteaminom, ki vam jih je predpisal zdravnik.
Since Orbactiv is given as an infusion (drip) into a vein, you may get reactions where the needle is inserted, including itching.
Ker se zdravilo Orbactiv daje v obliki infuzije (kapanja) v veno, se lahko na mestu vstavitve igle pojavijo reakcije, vključno s srbenjem.
Since palonosetron may induce dizziness, somnolence or fatigue, patients should be cautioned when driving or operating machines.
Ker lahko palonosetron povzroči vrtoglavico, zaspanost in utrujenost, je potrebno bolnike, ki upravljajo s stroji in voznike na te učinke opozoriti.
Since Pandemic influenza vaccine H5N1 MedImmune has been granted a conditional approval, the company that markets Pandemic influenza vaccine H5N1 MedImmune will conduct studies to gather more information on its effectiveness and side effects during its use in a pandemic as well as its side shelf life.
Ker je cepivo proti pandemski gripi H5N1 MedImmune pridobilo pogojno dovoljenje za promet, bo družba, ki ga trži, izvedla študije, v katerih bo zbrala več informacij o njegovi učinkovitosti in neželenih učinkih pri uporabi med pandemijo ter roku uporabnosti.
Since patients treated with antipsychotics often present with acquired risk factors for VTE, all possible risk factors for VTE should be identified before and during treatment with aripiprazole and preventive measures undertaken (see section 4.8).
Ker imajo bolniki, ki se zdravijo z antipsihotiki pogosto pridobljene dejavnike tveganja za VTE, je potrebno pred uvedbo zdravljenja in med zdravljenjem z aripiprazolom identificirati vse možne dejavnike tveganja za VTE in ustrezno preventivno ukrepati.
Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are at a higher risk of developing anti-natalizumab antibodies and/or hypersensitivity upon redosing, the presence of antibodies should be evaluated and if these remain positive in a confirmatory test after at least 6 weeks, the patient should not receive further treatment with TYSABRI.
Ker za bolnike, ki so bili izpostavljeni začetnemu kratkotrajnemu odmerjanju zdravila TYSABRI, nato pa so za dalj časa prekinili zdravljenje, obstaja višje tveganje za razvoj protiteles proti natalizumabu in/ali preobčutljivostnih reakcij po ponovnem odmerjanju zdravila, je pri njih treba oceniti prisotnost protiteles in če potrditveni test po vsaj šestih tednih pokaže njihovo prisotnost, se bolnika ne sme več zdraviti z zdravilom TYSABRI.
Since patients with an active hairy cell leukaemia mostly present with low blood counts, especially low neutrophil counts, more than 90% of the cases have transient severe neutropenias (< 1.0 x 109/l).
Ker imajo bolniki ob odkritju aktivne dlakavocelične levkemije večinoma nizke koncentracije krvnih celic, posebno nevtrofilcev, ima več kot 90 % primerov prehodne hude nevtropenije (< 1,0 x 109/l).
Since Prac-tic completely eliminates egg production, it breaks the flea life cycle.
Ker Prac-tic v celoti zavira produkcijo jajčec, s tem prekine življenjski ciklus bolh.
Since Pradaxa® is eliminated predominantly by the kidneys, adequate diuresis must be maintained.
Ker se zdravilo Pradaxa® pretežno izloča skozi ledvice, mora biti zagotovljena zadostna diureza.
Since Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics is expected not to be used in an emergency situation, its administration during pregnancy might be deferred as a precautionary approach.
Ker se ne pričakuje, da bi se cepivo Prepandemic Influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics uporabljalo v nujnih situacijah, se lahko uporaba med nosečnostjo preloţi kot previdnostni ukrep.
Since PREZISTA once daily has also been registered for use in treatment-experienced adults without darunavir resistance associated mutations (DRV-RAMs)* and who have plasma HIV-1 RNA < 100,000 copies/ml and CD4+ cell count ≥ 100 cells x 106/l, the same indication of PREZISTA once daily applies to treatment-experienced children 3 to 17 years weighing at least 15 kg.
Ker je zdravilo PREZISTA enkrat na dan registrirano tudi za uporabo pri odraslih bolnikih z izkušnjami z ART, ki nimajo z rezistenco za darunavir povezanih mutacij (DRV-RAM) * in imajo plazemsko koncentracijo HIV-1 RNK < 100,000 kopij/ml in število CD4+ celic ≥ 100 celic x 106/l, velja ta indikacija tudi za zdravljenje otrok z izkušnjami z zdravljenjem, starih 3 do 17 let in s telesno maso najmanj 15 kg.
Since prostaglandin synthesis inhibition may result in deterioration of renal function and fluid retention, caution should be observed when administering Dynastat in patients with impaired renal function (see section 4.2) or hypertension, or in patients with compromised cardiac or hepatic function or other conditions predisposing to fluid retention.
Ker lahko zavrtje sinteze prostaglandinov poslabša delovanje ledvic in povzroči zastajanje tekočine, je treba zdravilo Dynastat uporabljati previdno pri bolnikih z oslabelim delovanjem ledvic (glejte poglavje 4.2), hipertenzijo ali oslabelim delovanjem srca, jeter ali drugimi stanji, ki povečujejo zastajanje tekočine.
Since proteins are a source of nitrogen, Ravicti must be used together with a special low-protein diet to reduce the intake of nitrogen, and sometimes with dietary supplements (depending on the daily protein intake needed for growth and development).
Ker so beljakovine vir dušika, je treba zdravilo Ravicti uporabljati skupaj s posebno dieto z nizko vsebnostjo beljakovin za zmanjšanje vnosa dušika in včasih s prehranskimi dodatki (odvisno od dnevnega vnosa beljakovin, potrebnih za rast in razvoj).
Since radium-223 is neither metabolised by the liver nor eliminated via the bile, hepatic impairment is not expected to affect the pharmacokinetics of radium-223 dichloride.
Ker se [223Ra]radij ne presnavlja v jetrih in se ne izloča z žolčem, ni pričakovati, da bi jetrna okvara vplivala na farmakokinetiko [223Ra]radijevega klorida.
Since Renagel does not contain calcium your doctor might prescribe additional calcium tablets. have a low amount of vitamin D in your blood.
Ker zdravilo Renagel ne vsebuje kalcija, vam utegne zdravnik predpisati dodatne kalcijeve tablete. vsebnost vitamina D v krvi pade, odvisno od vrste ledvičnih težav.
Since renal dysfunction may decrease the rate of elimination of dexrazoxane, patients with initial impaired renal function should be monitored for signs of haematological toxicity.
Ker lahko ledvična okvara zmanjša hitrost izločanja deksrazoksana, je treba bolnike z začetno okvaro ledvic spremljati za znake hematološke toksičnosti.
Since Renvela does not contain calcium your doctor might prescribe additional calcium tablets. have a low amount of vitamin D in your blood.
Ker Renvela ne vsebuje kalcija, vam utegne zdravnik predpisati dodatne kalcijeve tablete. pojavi nizka količina vitamina D v krvi.
Since results are assay and laboratory dependent, and the results may change over time, adjustment to the targeted therapeutic range must be made with a detailed knowledge of the site-specific assay used.
Ker so rezultati odvisni od metode in laboratorija in se lahko sčasoma spreminjajo, je treba tarčni terapevtski razpon prilagajati ob natančnem poznavanju uporabljene metode, specifične za center.
Since rilpivirine is highly protein bound, dialysis is unlikely to result in significant removal of the active substance.
Ker se rilpivirin močno veže na beljakovine, ni verjetno, da bi dializa odstranila pomembno količino zdravilne učinkovine.
Since rilpivirine is highly protein bound, dialysis is unlikely to result in significant removal of the active substance.
Ker se rilpivirin močno veže na beljakovine, ni verjetno, da bi dializa značilno odstranila zdravilno učinkovino.
Since RoActemra is given by a doctor or nurse, it is unlikely that you will be given too much.
Ker vam bo zdravilo RoActemra dal zdravnik ali medicinska sestra, ni verjetno, da bi ga dobili preveč.
Since safety after giving both inoculations at the same site has not been examined, it is advised to carry out the second vaccination at a different site than the first vaccination.
Varnost dajanja obeh odmerkov na isto mesto ni raziskana, zato je drugi odmerek priporočljivo dati na drugo mesto kot prvič.
Since saquinavir is highly protein bound, dialysis is unlikely to be beneficial in significant removal of the active substance.
Ker se sakvinavir močno veže na krvne proteine, dializa pri znatnem odstranjevanju zdravilne učinkovine verjetno ne bo koristna.
Since secukinumab binds to cynomolgus monkey and human IL-17A, its safety was studied in the cynomolgus monkey.
Ker se sekukinumab veže tako na človeški interlevkin-17A kot na IL-17A opic cinomolgus, so varnost uporabe sekukinumaba proučevali na opicah cinomolgus.
Since Sevelamer carbonate Zentiva does not contain calcium your doctor might prescribe additional calcium tablets. have a low amount of vitamin D in your blood.
Ker Sevelamer carbonate Zentiva ne vsebuje kalcija, vam utegne zdravnik predpisati dodatne kalcijeve tablete. pojavi nizka količina vitamina D v krvi.
Since significant bradycardia may be poorly tolerated in patients with known ischaemic heart disease (including angina pectoris), cerebrovascular disease, history of myocardial infarction, congestive heart failure, history of cardiac arrest, uncontrolled hypertension or severe sleep apnoea, Gilenya should not be used in these patients.
Bolniki z ugotovljeno ishemično boleznijo srca (kar vključuje tudi angino pektoris), s cerebrovaskularno boleznijo, z anamnezo miokardnega infarkta, s kongestivnim srčnim popuščanjem, z anamnezo zastoja srca, z neurejeno hipertenzijo ali s hudo obliko apneje v spanju slabo prenašajo pomembno bradikardijo, naj zato ne uporabljajo zdravila Gilenya.
Since sildenafil (and its major circulating
Ker je sildenafil (in njegov glavni krožeči